N-(3-dibenzothiophen-4-ylphenyl)-N-(4-dibenzothiophen-1-ylphenyl)dibenzofuran-1-amine
C48H29NOS2 — CID 164955606
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-(3-dibenzothiophen-4-ylphenyl)-N-(4-dibenzothiophen-1-ylphenyl)dibenzofuran-1-amine
N-(3-dibenzothiophen-4-ylphenyl)-N-(4-dibenzothiophen-1-ylphenyl)dibenzofuran-1-amine (PubChem CID 164955606) has the molecular formula C48H29NOS2 and a molecular weight of 699.90 g/mol. Its IUPAC name is N-(3-dibenzothiophen-4-ylphenyl)-N-(4-dibenzothiophen-1-ylphenyl)dibenzofuran-1-amine.
Molecular Properties
| Compound Name | N-(3-dibenzothiophen-4-ylphenyl)-N-(4-dibenzothiophen-1-ylphenyl)dibenzofuran-1-amine |
|---|---|
| PubChem CID | 164955606 |
| Molecular Formula | C48H29NOS2 |
| Molecular Weight | 699.90 g/mol |
| Exact Mass | 699.17 |
| IUPAC Name | N-(3-dibenzothiophen-4-ylphenyl)-N-(4-dibenzothiophen-1-ylphenyl)dibenzofuran-1-amine |
| SMILES | c1cc(-c2cccc3c2sc2ccccc23)cc(N(c2ccc(-c3cccc4sc5ccccc5c34)cc2)c2cccc3oc4ccccc4c23)c1 |
| InChI | InChI=1S/C48H29NOS2/c1-4-20-41-38(14-1)47-40(19-10-21-42(47)50-41)49(32-27-25-30(26-28-32)34-16-9-24-45-46(34)39-15-3-6-23-44(39)51-45)33-12-7-11-31(29-33)35-17-8-18-37-36-13-2-5-22-43(36)52-48(35)37/h1-29H |
| InChIKey | KPOQTWMFJRUGQE-UHFFFAOYSA-N |
| XLogP | 15.13 |
| TPSA | 16.38 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 52 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 699.90 |
| LogP ≤ 5 | 15.13 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 164955606 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.